Jennifer Woyach, MD, and Seema Bhat, MD have published their latest work in @TheLancet. Congratulations on this outstanding achievement!
https://t.co/3ozMUrfEJ9
Transcription factor EB exerted a protective effect against endothelial cell injury and cardiac dysfunction in mouse models, underscoring its potential as a therapeutic target for mitigating doxorubicin-induced cardiotoxicity. https://t.co/fRTjxCFoGe
We're still accepting applications for our 2026-2027 Cardio-Oncology Fellowship, with an opportunity to train at a high-volume CV center as well as an NCI-designated Comprehensive Cancer Center. @OSUWexMed@OSUCCC_James . Learn more: https://t.co/lAXP1QrECP #cardioonc#aha2025
🚨 New member alert!!! 🚨 Hooray for Marios Arvanitis, MD, as he joins Cardiovascular Medicine and the #DHLRI! His research program addresses genetic basis of atherosclerosis. Read more here: https://t.co/QdJJdzxdEi
@OSUWexMed@OhioStateMed
Arrhythmia Challenges in #cardioonc--a problem we all see, but still an elusive clinical issue.
@OSUWexMed@AdamPotterMDPhD@SnehaSharmaDO#jonathanwright review the whole spectrum of arrhythmias & management in cancer & 💊 interactions to watch for!
https://t.co/2h0TDxDBzQ
7/🧵
Can exercise interventions improve heart health in stem cell transplant patients? A new RCT shows that a multi-component activity program preserves cardiorespiratory fitness and cardiac function in adults undergoing allo-SCT🏃♂️💓https://t.co/szSBkvLLwZ